Businesses base decisions on their current and future data. To steer a company in the right direction, leaders should maintain data integrity.
The US Food and Drug Administration (FDA) released a draft guidance on April 3 providing recommendations to sponsors and testing sites on data integrity for bioavailability and bioequivalence (BA/BE) ...